Detected ·
Solstice Oncology
$225M—
Solstice Oncology launched today with a $225M Series A to advance porustobart, targeting colon cancer treatment before surgery.
- Website
- www.solsticeoncology.com
- Amount
- $225 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-10 00:25:06 UTC
- Signal ID
- 796d429d-14c9-4662-ab28-bdc23546df38
As the API returns it
{
"id": "796d429d-14c9-4662-ab28-bdc23546df38",
"created_at": "2026-09-10T00:25:06.323208Z",
"company_name": "Solstice Oncology",
"company_website_url": "www.solsticeoncology.com",
"company_linkedin_url": "https://www.linkedin.com/company/solsticeoncology",
"event_type": "funding",
"funding_amount": 225000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Solstice Oncology launched today with a $225M Series A to advance porustobart, targeting colon cancer treatment before surgery.*"
}